tiprankstipranks
Trending News
More News >
Lonza Group (CH:LONN)
:LONN
Switzerland Market
Advertisement

Lonza Group Ltd (LONN) Earnings Dates, Call Summary & Reports

Compare
6 Followers

Earnings Data

Report Date
Jan 28, 2026
TBA (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
9.09
Last Year’s EPS
7.99
Same Quarter Last Year
Based on 9 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 23, 2025|
% Change Since: -3.65%|
Earnings Call Sentiment|Positive
Lonza delivered strong financial results and upgraded its outlook for the CDMO business, citing robust sales growth and high demand across several segments. However, challenges in specialized modalities and currency impacts presented obstacles. The company's strategic transformations are ongoing, with positive signs in its core business sectors.
Company Guidance -
Q4 2025
During the Half Year Results 2025 Investor and Analyst Conference Call, Lonza provided detailed guidance on their financial performance and future outlook. The company reported CHF 3.6 billion in sales, reflecting a 19% constant exchange rate (CER) sales growth compared to 2024, resulting in a core EBITDA of CHF 1.1 billion with a margin of 29.6%. Lonza's CDMO business, excluding Capsules and Health Ingredients (CHI), showed a 23.1% sales growth with a core EBITDA margin slightly above 30%. Consequently, Lonza upgraded its CDMO outlook for the full year 2025, projecting CER sales growth of 20% to 21% and a core EBITDA margin of 30% to 31%. The company highlighted strong demand across its business platforms, particularly in Integrated Biologics and Advanced Synthesis, and maintained resilience against potential U.S. tariffs. Lonza also discussed its planned exit from the CHI business, emphasizing strategic transformation and growth initiatives.
Robust H1 2025 Performance
Lonza delivered CHF 3.6 billion in sales across the group, translating into 19% CER sales growth compared to 2024. The core EBITDA was CHF 1.1 billion, representing margin growth of 0.4 percentage points to 29.6%.
CDMO Business Growth
The core CDMO business, excluding CHI, saw 23.1% sales growth leading to a core EBITDA margin slightly above 30%. The CDMO outlook for full year 2025 was upgraded to 20% to 21% CER sales growth and a core EBITDA margin of 30% to 31%.
Integrated Biologics Surge
Integrated Biologics reported almost 40% CER sales growth compared to H1 2024, supported by the Vacaville acquisition and sustained high demand, resulting in a core EBITDA margin of 36%.
Advanced Synthesis Performance
Advanced synthesis reported above 18% CER sales growth compared to H1 2024 with a core EBITDA margin reaching 40.3%, an increase of 6.9 percentage points versus H1 2024.

Lonza Group Ltd (CH:LONN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:LONN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 28, 2026
2025 (Q4)
9.09 / -
7.99
Jul 23, 2025
2025 (Q2)
7.06 / 7.51
7.026.98% (+0.49)
Jan 29, 2025
2024 (Q4)
7.99 / 7.99
6.2727.43% (+1.72)
Jul 25, 2024
2024 (Q2)
5.08 / 7.02
6.1214.71% (+0.90)
Jan 26, 2024
2023 (Q4)
6.85 / 6.27
7.43-15.61% (-1.16)
Jul 21, 2023
2023 (Q2)
8.32 / 6.12
7.28-15.93% (-1.16)
Jan 25, 2023
2022 (Q4)
7.10 / 7.43
5.6731.04% (+1.76)
Jul 22, 2022
2022 (Q2)
7.30 / 7.28
6.974.45% (+0.31)
Jan 26, 2022
2021 (Q4)
8.00 / 5.67
6.48-12.50% (-0.81)
Jul 23, 2021
2021 (Q2)
3.89 / 6.97
7.44-6.32% (-0.47)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CH:LONN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 23, 2025
CHF555.00CHF570.60+2.81%
Jan 29, 2025
CHF590.47CHF574.98-2.62%
Jul 25, 2024
CHF518.97CHF555.91+7.12%
Jan 26, 2024
CHF364.93CHF417.36+14.37%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Lonza Group (CH:LONN) report earnings?
Lonza Group (CH:LONN) is schdueled to report earning on Jan 28, 2026, TBA (Confirmed).
    What is Lonza Group (CH:LONN) earnings time?
    Lonza Group (CH:LONN) earnings time is at Jan 28, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Lonza Group stock?
          The P/E ratio of Lonza Group Ltd is N/A.
            What is CH:LONN EPS forecast?
            CH:LONN EPS forecast for the fiscal quarter 2025 (Q4) is 9.09.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis